Activation of TNF alpha, IL1-beta and Type-i IFn Pathways in human umbilical vein endothelial cells During Dengue 2 Virus Infection by Warke, Rajas V
Worcester Polytechnic Institute
Digital WPI
Masters Theses (All Theses, All Years) Electronic Theses and Dissertations
2002-04-24
Activation of TNF alpha, IL1-beta and Type-i IFn
Pathways in human umbilical vein endothelial cells
During Dengue 2 Virus Infection
Rajas V. Warke
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-theses
This thesis is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Masters Theses (All Theses, All Years) by an
authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Warke, Rajas V., "Activation of TNF alpha, IL1-beta and Type-i IFn Pathways in human umbilical vein endothelial cells During Dengue 2
Virus Infection" (2002). Masters Theses (All Theses, All Years). 255.
https://digitalcommons.wpi.edu/etd-theses/255
Activation of TNF α, IL1-β and Type-I IFN Pathways in human 
umbilical vein endothelial cells During Dengue 2 Virus Infection  
 
                                                         
 
                                                          A Thesis  
 
                                            Submitted to the Faculty 
       
Of the  
 
 WORCESTER POLYTECHNIC INSTITUTE 
 
                         In partial fulfillment of the requirements for the  
 
      Degree of Master of Science 
 
          In Biology  
 
   By 
 
 
 
 
 
 
     Rajas V.Warke 
         
       May 1, 2002 
 
 
APPROVED: 
 
 
 
 
_________________   ____________________       ____________________ 
 
Irene Bosch, Ph.D.  David S. Adams, Ph.D.  Sam Politz, Ph.D. 
 
UMASS, Dept. of CIDVR      WPI     WPI  
 
Major Advisor  Committee Member   Committee Member    
 
 2
                                                    ABSTRACT 
 
 
           Differential Display technique was used for gene profiling in transformed human 
umbilical vein endothelial cell line (ECV 304) and primary human umbilical vein 
endothelial cells (HUVECs) to study the cellular response to viral infection.  After 
screening the mRNA from uninfected and infected HUVECs and ECV 304 cells with 16 
different random primers we identified 8 gene targets.  These genes included the human 
inhibitor of apoptotis-1 (h-IAP1), 2-5 oligoadenylate synthetase (2-5 OAS), 2-5 
oligoadenylate synthetase –like (2-5 OAS-like), Galectin-9 (Gal-9), MxA, Mx1, 
Regulator of G-protein signaling (RGS2) and endothelial and smooth muscle cell- 
derived neuropilin-like protein (ESDN). We have found that HUVECs were a better 
model to study gene expression during dengue 2 virus infection but not the transformed 
cell lines, ECV 304.  Of the 41 primer combinations utilized in ECV 304 cells detected 
only one up-regulated gene, h-IAP1 and 8 out of the 16 primer combinations tried for 
HUVECs.  We hypothesize the activation of two novel signaling pathways (Tumor 
necrosis factor-α (TNF-α), Interleukin1-β (IL1-β) in endothelial cells during D2V 
infection. Also, our data detected genes that are activated in the Type-I IFN (IFN-α/β) 
signaling pathway during dengue 2 virus infection in HUVEC.  
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                                              BACKGROUND 
 
 
Dengue Virus 
Virus Taxonomy  
 Dengue virus belongs to the family Flaviviridae, genus Flavivirus  which includes 
over 60 known pathogens for humans.  These include Yellow Fever Virus (‘flavi’ derived 
from Latin for yellow), Japanese Encephalitis Virus, a major cause of encephalitis in 
Asia, Tick-Borne Encephalitis Virus, which is present in central and eastern Europe, and 
West Nile Virus, which has attracted attention because of its recent introduction into the 
Western Hemisphere.  However, dengue virus (DV) is the most important flavivirus from 
the standpoint of worldwide morbidity and mortality (Rothman and Ennis, 2000).  The 
term dengue probably means prudishness or affection, which refers to “the particular 
tortuous, affected gait, which patients adopt in consequence of the pain” (Burke, 1988).  
History 
          Tracing the history of dengue has been difficult because the clinical features of 
classic dengue fever are not pathognomonic.  One of the earliest descriptions of an 
outbreak compatible with classical dengue fever (DF) is that of (Rush, 1789) who saw 
patients with this syndrome in Philadelphia, USA in 1780.  But descriptions of dengue 
like illnesses have been found as far back as the tenth century A.D. (Hayes and Gubler, 
1992).  Graham  first demonstrated that dengue fever was transmissible by mosquitoes 
in 1903.  The period from 1960 to the present has been characterized as the “twentieth-
century pandemic of dengue” (Halstead, 1992) with constant simultaneous circulation of 
multiple dengue virus serotypes.  Dengue hemorrhagic fever (DHF) was first recognized 
in Manila in 1956 (Rothman and Ennis, 2000).  
 8
 
 
Types of Dengue Virus 
           Dengue virus is classified into four different serotypes namely, type 1, 2, 3 and 4. 
Infection from any of the four serotypes of dengue virus can result in dengue fever or 
dengue hemorrhagic fever when heterologous infection has occured.  Within the dengue 
virus complex, sequence homology is in the range of 65% to 70% between viruses of 
different serotypes, and >90% between viruses within the same serotype (Burke, 1988; 
Rothman and Ennis, 2000). 
. 
 
Genome, Structure and Morphology 
          The dengue virion is a sphere with a diameter of 48 to 52 nanometers.  The 
genome is 11,000 base pairs in length.  The dengue genomic RNA is translated into a 
continuous single polyprotein, which is cleaved into individual proteins.  Dengue virus 
encodes 3 structural and 7 non-structural proteins.  The 3 structural proteins are located 
at the 5’ end of the reading frame and 7 non-structural proteins are located at the 3’ end. 
The virus replicates by translating into a polyprotein initially, which is cleaved into 
individual proteins by using the host proteases along with NS3 which is the encodes the 
viral protease (Fig. 1).  It is a positive strand RNA virus that is 11kb in length.  The virus 
preferentially infects macrophages, endothelial, epithelial and hepatic cells.   
           Among the structural proteins, the virus encodes 2 different proteins, a 58-kDa to 
60-kDa glycoprotein (E) and an 8-kDa protein (M); E is the major envelope protein and 
M the membrane protein. A 22-kDa protein called the pre-membrane protein (pre-M) is 
processed during maturation to form M.  The 3rd protein that the virus codes is the capsid 
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(C) protein, which associates with the viral nucleic acid.  The non-structural proteins are 
NS1, 2A, 2B, 3,4A, 4B and NS5.  NS5 codes for the viral RNA-dependent RNA 
polymerase responsible for the replication of the genome through a negative-stranded 
RNA intermediate.  NS3 is the viral protease that along with the host proteases cleaves 
the long single polyprotein after it is translated.  NS1 is essential for viral replication (Fig. 
2) (Fields, 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dengue Virus Genome Map
Fig. 1    Map of dengue virus genome. The structural proteins (C, prM and E are encoded to the 5’ end and 
the non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 are encoded towards the 3’ end 
of the genome. 
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        Fig. 2    Structure of dengue virus. From Burke, D.S., 1988 
 
 
 
Life Cycle 
          The dengue life cycle involves an arthropod vector, a female Aedes aegypti adult 
mosquito, A. albopitus and A. taylori also can serve as vector for dengue viral disease 
transmission. Humans are the only known vertebrate hosts for dengue virus infection 
(Fig. 3).  The virus is secreted into the mosquito saliva and the viral particles are 
transmitted through the saliva to the blood stream.  The host develops dengue viremia 
after ~ 7 days of incubation.  When this infected host is bitten by another A. aegypti 
mosquito, the virus disseminates and replicates throughout the mosquito and is secreted 
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into the mosquito’s saliva completing the cycle (Burke, 1988; Rothman and Ennis, 2000).  
The prevalence of Dengue in the world is intimately related to the mosquito population 
(Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
              Fig. 3    Life cycle of dengue virus (Burke, 1988) 
 
 
 
Clinical Manifestations 
           Dengue fever is an acute debilitating self-limited febrile illness while dengue 
hemorrhagic fever is an acute, potentially life threatening, capillary leak syndrome.  
During dengue hemorrhagic fever if the lost fluid is not replenished, circulating blood 
volume drops and leads to shock syndrome. Dengue fever is observed more frequently 
during primary infections while studies indicate that dengue hemorrhagic fever 
associates with secondary dengue infections. Marked leucopoenia is observed in 
patients with DF along with depression of neutrophil and monocyte counts.  The features 
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of DHF are hepatic damage, hemorrhagic manifestations detected by positive tourniquet 
test and marked thrombocytopenia.  The four serotypes cannot be distinguished on 
clinical grounds alone and hence confirmation by serological tests or virus detection is 
necessary for accurate diagnosis of dengue virus infection (Hayes and Gubler, 1992; 
Rothman and Ennis, 1999; Rothman and Ennis, 2000).  
 
Mechanism for Immunopathogenesis  
          The cellular receptor that the E protein from dengue virus adheres to during 
primary infections is still not known nor is it known if other host components present in 
the circulation contribute to such binding.  Dengue fever, which is seen mainly in primary 
infections lasts for 5- 7 days.  Dengue hemorrhagic fever, which correlates with 
secondary infections, is categorized into 4 grades depending on the condition of the 
infected host by WHO.  Grade 1, 2 and 3 for DHF and grade 4 for Dengue Shock 
Syndrome (DSS) (Burke, 1988).  The theory of immune enhancement, developed 
extensively by Hanstead, predicts that individuals who have been immunologically 
sensitized to one dengue virus serotype may develop nonneutralizing antibodies that 
actually enhance the entry of different serotype dengue viruses into mononuclear 
phagocytes, resulting in the release of mediators of vascular permeability (Halstead and 
O'Rourke, 1977).  Hence, there are preexisting antibodies induced by the previous 
dengue infection that bind to the new virus serotype but do not neutralize infection 
instead lead to a more severe infection.  This is known as Antibody Dependent 
Enhancement (ADE) of infection.  Fcγ receptors I and II are believed to participate in 
viral entry during ADE.  Immunological studies of patients infected with dengue virus 
suggest that many tissues may be involved, as viral antigens are expressed in liver, 
lymph node, spleen, and bone marrow.  It is yet not known how the same virus can 
produce a mild versus outcomes.  The progression of DHF likely reflects a complex 
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interplay between host and viral factors and the production of inflammatory cytokines 
levels has shown to be implicated in the outcome (Rothman and Ennis, 2000). TNF α 
has been shown to correlate plasma leakage and shock in animal models of dengue 
infection as well as in humans (Diamond et al., 2000; Halstead, 1988; Halstead, 1992; 
Rothman and Ennis, 1999; Tracey and Cerami, 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4   World Distribution of Dengue in 1999. From The Center for Disease Control 
Public Health Image Library. (http://phil.cdc.gov/Phil/default.asp) 
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Differential Display technique 
           In this study we used a differential display technique to identify candidate genes 
differentially expressed during D2V infection in HUVEC and ECV 304 cells.  The 
Differential display (DD) technique was developed by Peng Liang and Arthur B. Pardee 
to identify differentially expressed genes in various cells or under altered conditions 
(Liang and Pardee, 1992).  It is a very powerful method that allows the comparison of 
similar cells or tissue types and the identification and isolation of differentially expressed 
genes (Martin and Pardee, 1999).  Higher organisms like humans, contain about 100,000 
different genes of which only a fraction, perhaps 15%, are expressed in any individual 
cell the number of aleatory combinations generated from the random primers will in 
theory, cover the expression repertoire of the cell. ).  DD is distinguished from related 
methods for its low stringency, competitive PCR step that uses primer pairs (arbitrary and 
anchor primer) to target the 3’ ends of messenger RNAs.  The anchor 3’ primer in DD 
hybridize with the polyadenylate [poly (A)] tail present in eukaryotic mRNA’s to anchor 
the primer at the 3’ end of the mRNA, with one additional 3’ bases.  Hence, by 
probability each anchor primer will recognize 1/3 of the total mRNA population because 
there are 3 (AT, GT, CT) different combinations of the last 3’ base, committing T as the 
penultimate base (Liang and Pardee, 1992).  The differentially expressed gene fragments 
can be excised from the DD gel, identified, and used to prepare specific primers for PCR 
and to study gene expression levels (Fig. 5Alternately more complex, Subtractive 
hybridization and high density DNA microchips are used to study mRNAs expression.  
          The advantages of DD over subtractive hybridization are that it is much quicker, 
allows simultaneous detections of both groups (treated and untreated) of differentially 
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expressed genes, it is a very sensitive technique, and very small quantities of RNA 
containing the template (200 ng) are sufficient (Bosch et al., 2000) as compared to 
subtractive hybridization which requires 50 times more RNA.  Also, while performing 
the subtractive hybridization, detection of highly homologous proteins within a gene 
family or identifying isoforms of the same gene is very unlikely.  
          DD has advantages over DNA microchips also in some aspects.  It is cost- effective 
and does not require bioinformatics for analysis of the results.  Hence, we selected the 
DD technique, to identify differentially expressed bands in ECV 304 and HUVECs 
during D2V infection, instead of subtractive hybridization or DNA microchips (Liang 
and Pardee, 1992; Martin and Pardee, 1999). 
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mRNA Population
 Reverse Transcription
PCR Amplification
 Denaturing Polyacrylamide Gel
dNTPs
  Sensiscript Reverse Transcriptase
GAAAAAAAAAAA-An
CAAAAAAAAAAA-An
TAAAAAAAAAAA-An
5’AAGCTTTTTTTTTTTG-3 ’ (H-T11G)
CAAAAAAAAAAA-An
GTTTTTTTTTTTCGAA
5’-AAGCTTGATTGCC-3 ’  (H-AP 1)
5’-AAGCTTTTTTTTTTTG-3 ’  (H-T11G)
dNTPs
α-[33P-dATP]
Taq  DNA  Polymerase
AAGCTTGATTGCC
GTTTTTTTTTTTCGAA
AAGCTTGATTGCC
GTTTTTTTTTTTCGAA
                RNA Sample:             X            Y
Negative electrode (-)
Positive electrode (+)
 Differential Display Method
Fig. 5    Various steps involved in diffeential display technique. 
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Cell Lines           
           A transformed human umbilical vein endothelial cell line (ECV 304) and 
HUVECs were used in the study.  The ECV 304 cell line has been shown to be a good 
model to study dengue infection (Bonner and O'Sullivan, 1998).  The advantages of 
HUVECs over the ECV 304 cell line is that it is a much more biologically relevant 
endothelial cell system because it is a primary cell line as opposed to ECV 304 which is a 
transformed cell line.  
          Using the DD technique we found 7 genes to be up-regulated during D2V infection 
in HUVEC cells, namely h-IAP1, 2’-5’ OAS, 2’-5’ OAS like, Mx1, MxA, Gal-9 and 
RGS2, and one gene, (ESDN) was found to be down-regulated in HUVEC cells during 
D2V infection.  The identification of these genes helped us to detect three pathways 
involved during D2V infection which were previously unknown.  The technique and the 
pathways involved, including the genes they regulate, will be described below.    
 
TNF α Signaling Pathway 
          Tumor necrosis factor α (TNF α), a potent pro-inflammatory cytokine, has been 
found to be augmented in DHF patients.  It belongs to the ever growing family of trimeric 
cytokines and cell-surface proteins such as Fas ligand (FasL), lymphotoxin-α (LT-α), 
CD40 ligand (CD40L), TNF-related apoptosis-inducing ligand (TRAIL) and receptor-
activator of NF-κB (RANKL).  TNF α binds to the two receptors, TNFR1 and TNFR2 
and activates 3 different pathways, two transcription factors, NF-κB and AP-1, and the 
caspases.  The NF-κB pathway regulates the expression of cytokines and hence 
modulates the inflammatory response.  It also targets various anti-apoptotic genes thus 
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partially controlling cell survival.  AP-1 leads to activation of caspases which ultimately 
lead to cell death or apoptosis (Fig. 6).  The anti-apoptotic genes that NF-κB is known to 
regulate are Bcl- 2, A20, Bcl-x, IEX-1L and three members of the inhibitor of apoptosis 
(IAP) family, h-IAP1/ c-IAP2, h-IAP2/ c-IAP1 and XIAP.  Of all the known anti-
apoptotic genes, it has been shown that NF-κB preferentially up-regulates the expression 
of h-IAP1.  NF-κB transcriptionally regulates the expression of h-IAP1, and h-IAP1 itself 
can activate NF-κB.  Hence, there exists a positive feedback loop between NF-κB and h-
IAP1 leading to increased expression of h-IAP1.  Also, h-IAP1 is recruited to the TNF 
receptor by associating with the TNF receptor-associated factors (TRAF1 and TRAF2) 
(Fig. 6).  TRAF2 can interact with TRADD, which interacts, with TNFR2 or directly with 
TNFR1 but it has higher affinity for TRADD in comparison to TNFR1 or TRAF1 (Baud 
and Karin, 2001; Heyninck and Beyaert, 2001; Idriss and Naismith, 2000; Locksley et al., 
2001; Park et al., 2000; Tracey and Cerami, 1993).  Hence, signaling through the TNFR2 
receptor is more important since most of the TNF α signaling occurs through TNFR2.  h-
IAP1 has been demonstrated to interact with TRAF2 which is essential for the over 
expression of h-IAP1.  TRAF1 is not essential for up-regulating expression of h-IAP1 but 
its presence enhances the expression of h-IAP1 indicating that it might stabilize the 
interaction between TRAF2 and h-IAP1.  Overall, this further enhances the expression 
levels of h-IAP1 gene.  Downstream of its expression, h-IAP1 induces the proteolytic 
degradation of caspase- 3, -7 and –9.  Previous studies have shown that in Jurkat T cells, 
Hela cells and in HUVEC cells TNF α stimulation leads to increased expression of h-
IAP1 (Chu et al., 1997) (Hofer-Warbinek et al., 2000) (Stehlik et al., 1998).  
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     TNF-α Signaling Pathway
Caspase 8
Caspase 3
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NIK/ MEKK-1ASK-1
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IκB-P
Free NF-κB
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Cleaves
Extracted and modified from Baud and Karin, TRENDS in Cell Biology vol. 11 (9):372-
377, 2001
h-IAP1
Transcriptional Activation
Anti-apoptosis
Inflammation
Free NF-κB
h-IAP1
Fig 6    Signal transduction through the TNF α signaling pathway 
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IL1-β Signaling Pathway 
          Interleukin1- β (IL1-β), also a pro-inflammatory cytokine, which signals through 
the IL-1 receptor, activates NF-κB.  Activation of NF-κB leads to the expression of other 
pro-inflammatory cytokines (You et al., 2001).  It has been demonstrated that IL1-β also 
can up-regulate the expression of the h-IAP1 gene in HUVEC cells (Bannerman et al., 
2002) (Wang et al., 1996) (Wrighton et al., 1996).  Also, IL1-β has been shown to 
enhance the up-regulation of expression of Gal-9, an eosinophil chemoattractant (Fig 7) 
(Yoshida et al., 2001).  
 
 
           
           
 
 
 
 
 
 
 
 
 
 
 
   IL1-β Signaling Pathway
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           Toll like receptors (TLR) are a family of innate immune-recognition receptors that 
induce antimicrobial immune responses on recognizing lipopolysaccharide (LPS) or other 
microbial products.  Toll like receptor-3 (TLR 3) recognizes dsRNA and activates the 
type-1 IFN pathway in endothelial cells (Miettinen et al., 2001) and NF-κB (Alexopoulou 
et al., 2001) (Alexopoulou et al., 2001).  Hence, TLR3 activation may lead to inhibition 
of protein synthesis and increased production of inflammatory cytokines, possibly 
playing a role in the host defense against viruses.  
 
Type-1 IFN Pathway 
          The type-1 interferons are made by infected cells to directly induce an antiviral 
effect in neighboring uninfected cells and control viral spread.  The IFN pathway is 
among the first to be activated to induce an antiviral state and fight the viral infection 
(innate) before an immune response (adaptive) is developed. 2’-5’ OAS, PKR and Mx 
proteins recognize dsRNA and activate the type-1 IFN pathway (IFN-α and -β).  IFN-α 
and -β produced in response to viral infection inhibit cells growth, controls apoptosis, and 
will activate the expression of more genes which will lead to an inhibition of protein 
synthesis (Paul, 2001; Stark et al., 1998).   
          On recognizing dsRNA, PKR gets phosphorylated (activation) and phosphorylates 
eukaryotic initiation factor 2 (eIF2), which makes it nonfunctional and hence inhibits 
protein synthesis and viral replication.   
          IFN inducible 2’-5’ OAS is stimulated by dsRNA and produces a series of short 2’-
5’- oligoadenylates that converts inactive RNase L to active RNase L, which selectively 
degrades viral RNA (Bonnevie-Nielsen et al., 1995).  
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          Mx proteins, Mx1(Tezak et al., 2002) and MxA are also IFN-inducible that belong 
to the dyanin superfamily of GTPases that are involved in endocytosis and vesicle 
transport (Fig. 8).  The formation of large oligomers is essential for their anti-viral 
activity (Harcourt et al., 2000; Li et al., 2000; Rebouillat and Hovanessian, 1999; 
Rebouillat et al., 2000; Stark et al., 1998). 
          Induction of the IFN pathway also leads to an increase in expression of dsRNA-
responsive genes such as E-selectin, ICAM-1, VCAM-1, which regulate the numbers and 
types of leukocytes that accumulate at the site of infection, and IL1-β and IL-6 that 
activate the leukocytes and help to contain and eliminate the viral infection (Sen, 2001).   
Previous studies have shown dengue virus infection induces type I and II- IFN pathway 
in immune cells and induction of E-selectin and VCAM-1 in endothelial cells (Avirutnan 
et al., 1998; Diamond et al., 2000; Libraty et al., 2001; Rothman and Ennis, 1999).  Also 
the specific pathways stimulated downstream of the IFN receptors is not known yet.  
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Fig. 8    dsRNA recognition pathways  
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PROJECT PURPOSE 
         
          The first goal of this project was, to identify potential candidate genes 
differentially expressed in HUVEC cells during dengue 2 virus infection using 
differential display technique.  The second goal was, to identify prominent cellular 
pathways that are activated or regulated by these differentially displayed genes during 
D2V infection to eventually delineate possible interventions to counteract viral 
persistence and its effect on target cells.  We investigated ECV 304 cells and HUVEC 
cells as model systems for endothelial cells. 
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                                   MATERIAL AND METHODS 
 
 
Cell Culture 
          HUVEC were purchased (Clonetics Corporation, San Diego, CA) and maintained 
in endothelial cell culture media (EGM Bullet Kit; Clonetics Corporation) 
supplemented with Hydrocortisone (1 mg/ml), 50 mg/ml Gentamicin sulphate 
Amphotericin-B (GA-1000), 2% Fetal Calf Serum (FCS) 
10 µg/ml Human Recombinant Epidermal Growth Factor (hEGF) and 3 mg/ml Bovine 
Brain Extract (BBE) at 37°C in humidified air containing 5% CO2 according to the 
manufacturer’s instructions.  Only cells from passage two were used for experiments.  
The human umbilical vein endothelial cell line (ECV 304), obtained from American Type 
Culture Collection (ATTC) (Manassas, VA) was grown in medium 199 (Life 
Technologies, Grand Island, N.Y.) supplemented with 10% FCS (Life Technologies), 
Earle’s medium, 2 mM L-glutamine and 2,200 mg/L of sodium bicarbonate at 37°C in 
humidified air containing 5% CO2.  
 
Primer Sequences 
The sequences  of oligonucleotide primers obtained from Genhunter (Nashville, TN) are 
shown in Table 1. 
 
                                                               Table 1. 
Gene Forward primer 5’–3’ Reverse primer 5’-3’ 
h-IAP1 cagaagacacagacgtcttta cgaactgtacccttgattgta 
2’-5’ OAS actttaaaaaccccattattgaaa ggagaggggcagggatgaat 
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2’-5’ OAS-like catcgtgaacccttatgagc ctgctggtcttcaatctgc 
Gal-9 cctgcccagtgctcagaggtt gcacatgggtcagctggatga 
ESDN ctacctttaaaccagaagaa ccccatcccttcctgctc 
RGS2 cggaattctgtgaagaaaatat gcatgaggctctgtggtgattt 
MxA gccaggaccaggtatacag gcctgcgtcagccgtgc 
Mx1 gccaggaccaggtatacag gctccttcaggagccagc 
 
 
Infection of Endothelial Cells 
          Monolayers of ECV304 cells in 6 well micro titer dishes were resuspended in 
medium 199 containing 2% FCS, Earle’s medium, 2 mM L-glutamine and 2,200 mg/L of 
sodium bicarbonate.  Monolayers of HUVEC cells in 6 well microtiter dishes were 
resuspended in endothelial cell culture media (EGM Bullet Kit; Clonetics Corporation) 
supplemented with half quantity of Hydrocortisone (1 mg/ml), Gentamicin sulphate 
Amphotericin-B (GA-1000), 2% Fetal Calf Serum (FCS), 10 µg/ml Epidermal Growth 
Factor Human Recombinant (hEGF) and 3 mg/ml Bovine Brain Extract (BBE).  Dengue 
2 virus New Guinea C (D2V NGC) was added to confluent monolayers of cells at a 
multiplicity of infection (M O I) of 1, and incubated at 37°C in humidified air containing 
5% CO2 for 12-14 hours.  The culture supernatant was then removed, and fresh growth 
medium containing 10% FCS was added to each well.  After 48 hours of infection, cells 
were harvested, centrifuged at 500 g for 7 min at 4° C, washed with PBS, pelleted and 
stored at –70°C for future experiments.  
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Total Cellular RNA Preparation 
           Total cellular RNA was extracted from 20 million (20 × 106) uninfected or 
infected HUVEC or ECV304 cells using an RNA Extraction Kit (Qiagen, Germany).  
Typically one million cells (1 × 106 cells) produced 10 µg of total RNA.  RNA was 
digested to eliminate residual DNA with DNase I using Message Clean Kit (GenHunter, 
Nashville, TN).  The RNA was resuspended in diethyl pyrocarbonate (DEPC)-treated 
dH2O for DD analysis (alternately; Promega RNA Extraction Kits  and Stratagene 
Absolute RNA Kits were used).  RNA was quantified by spectrophotometry (Bio 
Photometer, Eppendorf, Germany) at 260 nm.  
 
Reverse Transcription of RNA for Differential Display 
          RT was performed using Sensicript Reverse Transcriptase (Qiagen, Germany). 
cDNA was synthesized in 20 µl reactions containing 200 ng of HUVEC or ECV304 
mRNA, RT buffer (25 mM Tris-Cl, pH 8.3, 37.2 mM KCl, 1.5 mM MgCl2, 5 mM DTT) 
and 0.5 mM dNTP, 10 µmol/µl of H-T11C anchor primer (5’-AAGCTTTTTTTTTTTC-
3’) and RNase inhibitor (10 U/µl).  Reactions were incubated at 37°C for 60 min, then 
95°C for 5 min.   
 
Amplification of cDNA for Differential Display 
          PCR amplification of cDNA was achieved according to the RNAimage protocol 
(Genhunter, Nashville, Tx).  For the PCR reactions 10% of the RT reaction including Taq 
DNA Polymerase (Promega, Madison, WI) or TitaniumTMTaq polymerase that includes 
an antibody against Taq DNA Polymerase (Clontech, Palo Alto, CA) was used.  The PCR 
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reaction contained 200 nM of each primer (H-T11C anchor primer with either H-AP 1, 
12, 15, 21 and 42) (Genhunter, Nashville, Tx), 2 µl of 10X PCR buffer (final 
concentrations of 10 µM Tris-Cl, pH 8.4, 50 mM KCl, 1.5 mM MgCl2 and 5 mM DTT), 
25 µM dNTP mix, 3000 Ci/mmol  [α-33P] dCTP per reaction and 5 U/µl of Taq 
Polymerase (Promega) in a total volume of 20 µl.  Reactions were cycled at 94°C for 30 
sec, 40°C for 2 min, and 72°C for 30 sec for 40 cycles, followed by 72°C for 10 min.  
Reactions which included 0.4 µl of Titanium TMTaq DNA Polymerase contained 2 µl of 
Titanium Taq PCR buffer (final concentrations of 10 µM Tris-Cl, pH 8.4, 50 mM KCl, 
1.5 mM MgCl2 and 5 mM DTT), 0.4 µl of dNTP, and 200 nM primer mix, and 3000 
Ci/mmol of [α-33P] dCTP per 50 µl reaction in PCR-grade water. Conditions for 
Titanium Taq PCR were set at 95°C for 1 min, 40 cycles at 93°C for 30 sec, 40°C for 2 
min, 68°C for 30 sec, and a final step at 68°C for 10 min. 
 
 
Gel Electrophoresis of cDNA Fragments for Differential Display 
          PCR reactions were electrophoresed on extended-format denaturing 6% 
polyacrylamide gels using the programmable Genomyx LR DNA sequencer (Beckman 
Coulter, Columbia, MD). 
 
Re- Amplification of cDNA probes for Differential Display 
          The RNAimage protocol was followed to re-amplify candidate bands observed on 
the DD gels.  The bands were extracted from the denaturing polyacrylamide gel by 
soaking in 100 µl of 2X PCR buffer (final concentrations of 10 µM Tris-Cl, pH 8.4, 50 
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mM KCl, 1.5 mM MgCl2 and 5 mM DTT) for 10 min.  This supernatant was treated with 
3M Sodium Acetate (10 µl), 5 µl of Glycogen (10 mg/ml) and 450 µl of 100% Ethanol, 
stored at –70°C for 30 min, and pelleted by centrifugation.  The pellet was rinsed with 
200 µl Ethanol, air dried and dissolved in 10 µl dH2O.  This extracted DNA was 
amplified using the RNAimage protocol (GenHunter).  The 40 µl PCR reaction included 
4 µl of DNA, 4 µl of 10X PCR buffer (final concentrations of 10 µM Tris-Cl, pH 8.4, 50 
mM KCl, 1.5 mM MgCl2 and 5 mM DTT), 3.2 µl of dNTP (250 µM), 200 nM of 
primers, 200 nM of H-T11C and 2.5 U of Taq Polymerase (Promega).  Reactions were 
subjected to 40 rounds of PCR amplification at 94°C for 30 sec, 40°C for 2 min, and 
72°C for 30 sec, followed by 72°C for 10 min.  L35A DNA served as a control to exclude 
variations between samples.  The amplified PCR products were electrophoresed in 1.5% 
agarose gels (Life technologies, Grand Island, N.Y.) containing 0.5 µg/ ml ethidium 
bromide for staining.  Results were documented with Quantity One Software version 
4.2.3 (Biorad, Italy). 
 
Northern Blot 
          Total cellular mRNA was isolated using Trizol reagent (Gibco BRL, Gaitherburg, 
MD).  10 µg of RNA was electrophoresed on a standard formaldehyde 1% agarose gel. 
The northern blot protocol from the 2nd edition of Molecular Cloning, A Laboratory 
Manual (Maniatis, 1989) was followed to transfer the RNA to a nitrocellulose membrane. 
Samples were electroporesed in buffer containing 0.1 M MOPS (pH 7.0), 40 mM sodium 
acetate and 5 mM EDTA (pH 8.0), and blotted overnight using 20X SSC onto a 
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nitrocellulose membrane.  RNA was cross-linked to the nitrocellulose membrane by 
exposing to UV light for 3 minutes.  
          Membranes were hybridized with α-[32P] dCTP-labeled DNA restriction fragments 
specific to h-IAP1 using the Random Primed Labeling Kit (Roche, IN, USA).  The h-
IAP1 fragment (probe) was produced by amplification of h-IAP1 by PCR using 
5’cagaagacacagacgtcttta3’ (forward primer) and 5’cgaactgtacccttgattgta3’ (reverse 
primer).  In this protocol, the h-IAP1 DNA was denatured at 100°C for 10 min, and then 
cooled on ice.  A final volume of 20 µl contained 1 µl of Klenow enzyme (2 U), 3 µl of 
dATP, dGTP, dTTP mixture (0.5 µM), 5 µl of [α32P] dCTP (3000 Ci/mmol) and 25 ng 
denatured DNA in dH2O.  This reaction was incubated at 37°C for 30 min, followed by 
65°C for 10 min to stop the reaction.  Unincorporated nucleotides were removed using 
Quick Spin G-25 Sephadex columns.  Initially the membranes were washed with 1X 
SSC, 0.1% SDS, and later with 0.2X SSC, 0.1% SDS.  Membranes were analyzed by 
autoradiography after exposure to Kodak BioMax films at –70°C for 72 hours using 
intensifying screens.  Radioactivity was quantified using a Phosphoimager. 
 
Gel Extractions and DNA Sequencing 
          The QIAquick Gel extraction kit protocol (Qiagen, Germany) was used to extract 
DNA from samples run on 1.5% Agarose gels.  Purified DNA was eluted in dH2O instead 
of Buffer EB (10 mM Tris-Cl, pH 8.5) and quantified by spectrophotometry using a 
BioPhotometer (Eppendorf, Germany) at 260 nm.  These DNA samples were sequenced 
in the UMASS Medical School sequencing facitlity using the anchor primer H-T11C.  
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PCR Extractions  
          PCR mixes were subjected to the QIAquick PCR Purification kit protocol (Qiagen, 
Germany).  DNA was eluted in dH2O instead of Buffer EB (10 mM Tris-Cl, pH 8.5) and 
quantified by spectrophotometry using a BioPhotometer (Eppendorf, Germany) at 260 
nm.  These DNA samples were sequenced using the anchor primer H-T11C.  
  
Semi-Quantitative RT-PCR 
          0.2 µg of total cellular RNA obtained from infected and un-infected cells was 
reverse transcribed using Omniscript/ Sensiscript Reverse Transcriptase (Qiagen, 
Germany) in the presence of 1 µM of anchor primer, and a dNTP concentration of 500 
µM in a volume of 20 µl.  Reverse transcription (RT) was performed at 37°C for 60 min, 
followed by 94°C for 15 min.  The PCR reaction was performed using various quantities 
(0.5, 1 and 2 µl) of the cDNA obtained from infected and un-infected RNA samples in 
the RT step.  The 50 µl PCR reaction included 2.5 U of Taq DNA Polymerase (Clontech, 
Palo Alto, CA), 100 µM of dNTP, and 100 µM of primer.  This reaction mix was 
subjected to a PCR program: 94°C for 1 min, followed by varying cycles at 58°C for 1 
min, 72°C for 45 sec, and 94°C for 30 sec, and then 58°C for 1 min, and 72°C for 10 min. 
The cDNA obtained from the RT step was also utilized in a real-time PCR reaction. 
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Real-Time PCR (SYBR Green) 
          cDNA samples generated from a semi-quantitative RT step were used as template 
for a real-time PCR reaction.  Each 50 µl reaction included 1-4 µl of cDNA (containing 
200 ng of RNA) and 15.75 µl PCR master mix containing 5 µl of10X SYBR PCR Buffer, 
6 µl of 25 mM MgCl2, 4 µl of dNTP blend (2.5 mM dATP, 2.5 mM dCTP, 2.5 mM 
dGTP, 5 mM dUTP), 0.25 µl AmpliTaq Gold (1.25 U) and 0.50 µl AmpErase UNG (0.5 
U) in deionized water.  Five dilutions of a plasmid from 100 femtograms (fg) to 1 
nanogram (ng) (1/10 dilution series) were used as standard for the experiment, and L35A 
was used as an internal control for the unknown samples.  Reactions were cycled at 50°C 
for 2 min, 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec, and 60°C for 1 min 
in a Gene Amp PCR System 5700 (Perkin Elmer). 
 
Fluorescence Detection of Infected HUVEC Cells 
          D2V infected primary human umbilical vein endothelial cells were analyzed by 
FACs using intracellular labeling (Cytofix/Cytoperm Plus kit, Pharmingen/Becton 
Dickinson, San Diego, CA) with mouse polyclonal D2V antibody diluted 1:500 in PBS, 
purified from hyperimmune mouse ascitic fluid (ATCC), and a secondary antibody 
against mouse IgG coupled with FITC (Sigma). 
 
Multiplex PCR Reactions 
 
          For the multiplex PCR reaction, cDNA template was obtained from the semi-
quantitative RT step, and the CytoXpress Multiplex RT-PCR Kit protocol (BioSource 
International, CA) was followed.  The 50 µl reaction contained 4 µl of 3.12 mM dNTP, 5 
 33
µl of Taq DNA polymerase (2.5 U), 5 µl of 10x MPCR primers, 5 µl of 10x MPCR 
Buffer, 5 µl of 10x MPCR enhancer, and 5 µl of cDNA (200 ng/µl) in dH2O.  After an 
initial denaturation step at 96°C for 1 min, the PCR reaction was cycled 2 times at 96°C 
for 1 min, and 60°C for 4 min, followed by 30 cycles at 94°C for 1 min, and 60°C for 2.5 
min and a final step of incubation at 70°C for 10 min.  20 µl of PCR product was 
electrophoresed on a 1.5% agarose gel (Life Technologies, Grand Island, N.Y.) 
containing 0.5 µg / ml ethidium bromide for staining DNA.  
            Primary monocytes were isolated and infection was performed for 48hours. RT-
PCR was done as described elswere (Bosch et al., 2002). 
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                                                     RESULTS 
  
Differential Display Analysis of Dengue Infected ECV304 and HUVEC Cells 
           A combination of 41 different primers was used in an effort to identify DD genes 
in the ECV 304 cell line during D2V infection.  The list of the primers used was H-AP 1, 
2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 
28, 30, 31, 32, 41, 42, 43, 44, 45, 46, 47, 48 (Fig 9).  One of the bands excised from the 
D2V infected lanes using the H-AP 21/HT11C primer pair was identified as the human 
inhibitor of apoptosis-1 (h-IAP1) on sequencing (UMASS Medical School sequencing 
facility) and BLAST search (Fig 10).  This was the only DD-identified band that found an 
identity with a human expressed sequence tag in Genbank out of 45 bands analyzed by 
BLAST searches.  Most of the Genbank searches found genomic identities.  When DNase 
I treatment was used at the end of the RNA extraction, we observed elimination of the 
full length genomic DNA Genbank hits.  Hence, this might demonstrate that the genomic 
identities we had earlier encountered may have been due to contamination of the RNA 
with traces of genomic DNA. 
          The data from the DD analysis of ECV 304 cells indicated h-IAP1 was increased in 
dengue infection.  But EVC 304 is a transformed endothelial cell line while HUVEC is a 
primary endothelial cell line.  Perhaps the pattern of gene expression would be more 
accurate in a cell line that the virus usually infects, primary HUVEC cells, as compared 
to an immortalized cell line that has undergone changes during its transformation.  
Hence, DD analysis of HUVEC cells (a much more biologically relevant cell, compared 
to ECV 304) was used to study gene profiling during dengue 2 virus infection.  The 
random primers used were H-AP 1, 3, 4, 6, 8, 12, 15, 16, 19, 21, 22, 23, 41 and 42 in 
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various combinations.  Out of the 16 bands extracted from the DD gel, 8 bands found 
identifications with human expressed tags when the BLAST search against Genbank was 
used.  Six of these bands are shown in Fig 11.  The list of these identifications is shown 
in Table 1. 
 
             Table 2. Summary of Differentially displayed genes in HUVEC cells 
          Gene Name 
 
GenBank Acc.               Function 
   
1. h-IAP1 
Human inhibitor of 
apoptosis protein-1  
AF070674 Anti- apoptotic 
2. ESDN  
Endothelial and smooth 
muscle cell- derived 
neuropilin-like protein  
AF387547 Regulation of Vascular cell 
growth 
3.  2’-5’ Oligoadenylate 
synthetase  
XM_056785 Induction of IFN-α, ß  
4.  2’-5’ Oligoadenylate 
synthetase-like  
 Binds dsRNA but function 
unknown 
5. Mx1 
 Myxovirus (influence) 
resistance 1, homolog of 
murine (interferon-
inducible protein p78) 
M30817 Type1 IFN response 
6. MxA 
Interferon-induced cellular 
resistance mediator protein  
XM_009773 Type1 IFN response 
7. RGS 2 
Regulator of G-protein 
signaling 2 
XM_029884 Regulates G-protein 
signaling and T-cell 
activation 
8. Galectin 9 
Lectin, galactoside-binding, 
soluble 9 
NM_002308 Eosinophil 
Chemoattractant, cell 
adhesion, apoptosis and cell 
proliferation 
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Fig. 1    Differential Display using total RNA.  Total RNA was reverse
transcribed and this cDNA was then radioactively labeled with [α-
33P]dCTP during PCR reaction.  PCR product was analyzed on a  6%
DNA sequencing gel.  Lane 1 is infected sample, lane 2 is uninfected +
D2V virus and lane 3 is uninfected sample.  The arrows indicate a
amplified mRNA species found only in D2V infected HUVEC cells.
1   2   3       1   2    3     1    2   3      1    2   3      1   2   3      1    2   3      1   2   3
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FIGURE10.     Differentially displayed (DD) h-
IAP1 gene in EVC 304 cells during 48 hours of
D2V,NGC infection. The arrow  indicates a
differentially displayed band on a  6% denaturing
polyacrylamide gel that was identified using
primers HT11C / H-AP21. A sample containing
ECV 304 RNA spiked with D2V,NGC virus
(ECV 304+) was used to avoid false positives.
ECV 304          ECV 304+         ECV 304
                                                      + D2V
h-IAP1
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                  ESDN
RGS2
              Galectin - 9
2-5 Oligoadenylate
Synthetase
2-5 Oligoadenylate
Synthetase like
Mx1 and MxA
HUVEC HUVEC+ D2V HUVEC HUVEC+           D2V
HUVEC      HUVEC+           D2V         HUVEC      HUVEC+           D2V
HUVEC      HUVEC+             D2V HUVEC         HUVEC+              D2V
FIGURE 11.   Differentially displayed genes in HUVEC cells during  48 hours of D2V,NGC
infection. HUVEC RNA was used to prepare cDNA with Sensiscript reverse transcriptase (limit of
detection was 0.2 ng of total RNA in the RT reaction) and HT11C primer. The arrows indicate the
differentially displayed bands identified when HUVEC cells were infected with D2V,NGC
compared to control HUVEC cells (up-regulated in treated cells). The asterix indicates a down-
regulated cDNA when HUVEC cells are infected with D2V,NGC. Its presence can be seen in
uninfected cells. H-AP21-1, H-AP12, H-AP42, H-AP15, H-AP21-2, H-AP1 primers correspond to
2-5 OAS, Mx1/MxA, Gal-9, ESDN, 2-5 OAS-like genes respectively.
∗
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Flow Cytometry Analysis  
          Infected and uninfected HUVEC cells were fixed and permeabilized for detection 
of viral antigens using immunofluorescence as specified in Materials and Methods.  Cells 
were analyzed by FACs using antibodies against dengue virus to detect percent of 
infection.  10% infection was detected in one pilot experiment as shown in Fig. 12.  The 
mRNA extracted from these cells was utilized in the time course experiments. 
 
 
                A                                                                                         B     
 
 
 
 
 
 
 
 
  Uninfected                                                                                           Infected 
FIGURE 12.     Flow cytometry analysis to determine the percent infection of HUVEC cells with 
D2V,NGC. Uninfected (A) and D2V,NGC infected cells (B) were harvested after 50 hours of incubation. 
The cells were fixed, permeabilized and subjected to  intracellular labeling with mouse polyclonal D2V 
antibody diluted 1:500 in PBS, purified from hyperimmune mouse ascitic fluid (ATCC). The cells were 
stained with a secondary antibody against mouse IgG coupled with FITC and analyzed by FACscan. The 
M2 gate corresponds to 10% infection. 
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Semi-Quantitative RT-PCR in ECV 304 Cells 
          To confirm the up-regulation of h-IAP1 in ECV 304 cells during D2V infection, a 
semi-quantitative RT-PCR was performed on the total RNA extracted from uninfected 
and infected ECV 304 cells.  Three different quantities (0.5, 1 and 2 µl) of both 
uninfected and infected cDNA were used in the PCR reaction.  h-IAP1 was found to be 
up-regulated approximately 8 fold during D2V infection of ECV304 cells as shown in 
Fig. 13.  In two independent experiments, the same result was obtained.  Ribosomal 
protein gene L35A was used as a housekeeper gene in both experiments.  This data 
showed that h-IAP1 was indeed up regulated in ECV 304 cells during D2V infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ECV 304        ECV 304 + D2V
0.5        1         2         0.5        1         2
L35a 
h-IAP1
FIGURE 13.     Up-regulation of h-IAP1 
gene (~ 8 fold) in D2V,NGC infected ECV 
304 cells. ECV 304 cells were incubated 
with D2V,NGC for 48 hours and total 
RNA was obtained from uninfected and 
infected cells. RT-PCR was performed to 
check for up-regulation of the h-IAP1 
gene. Three different quantities of cDNA 
(0.5, 1, 2 µl) were used in the PCR step. 
L35a, a ribosomal protein gene was used as 
a control.  
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Semi-Quantitative RT-PCR in HUVEC Cells 
          Semi-quantitative RT-PCR analysis was performed for all the 8 genes identified by 
DD as potential candidates for differential expression during D2V infection of HUVEC 
(e.g., Fig 14).  The L35A gene was used as a housekeeper gene to standardize the results 
obtained in the experiments (Fig 15).  The fold induction (up-regulation or down-
regulation) of the 8 genes is shown in Table 2 (right column). 
           We performed RT-PCR on the 7 genes in ECV 304 mRNA confirmed to be 
differentially expressed in primary HUVEC cells.  3 out of the 7 genes differentially 
expressed in HUVEC cells were not found to be differentially expressed in ECV 304 
cells (data not shown).  This strongly indicates that the ECV 304 cell line model system 
appears not to be ideal for studying gene profiling in endothelial cells during D2V 
infection. 
 
 
  
 
 
 
 
 
 
 
0.5          1           0.5          1              0.5            1            0.5           1            0.5           1            0.5            1
  Uninfected          Infected        Uninfected           Infected        Uninfected       
    L35A                           IL-8                         h-IAP1 
100 bp 
marke
FIGURE 14.    Induction of h-IAP1 mRNA in D2V,NGC infected HUVEC. Total RNA was 
extracted from uninfected and infected cells and RT-PCR was performed after 48 hours  of 
D2V,NGC infection. L35a a  ribosomal protein gene was  used as a control and IL-8 was used 
as a  positive marker of infection. In the PCR step two different quantities of cDNA were used 
(0.5, 1 µl).    
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RGS2                                                     ESDN
Gal-9                                               2-5 OAS like
Mx1                                                       MxA
L35A
   0.5   1     2       0.5     1     2                                                 0.5    1      2    0.5   1     2
   0.5        1        0.5        1                                                  0.5   1     2      0.5      1      2
 0.5    1       2      0.5     1      2                                                0.5    1     2       0.5     1      2
    0.25         0.5            1          0.25           0.5           1
FIGURE 15.      Semi-quantitative RT-PCR analysis showing up-regulation
of 6 different genes in D2V ,NGC infected HUVEC. Total RNA was
extracted from uninfected HUVEC 48 hours post-infection. L35a was used
as housekeeper gene. 0.5, 1 and 2 µl of cDNA of uninfected and infected
samples was used in the PCR step for all reactions except for L35a in which
0.25, 0.5 and 1 µl of cDNA was used.
   uninfected   infected                                      uninfecetd    infected
uninfected                   infected
uninfected       infected                                     unifected         infected
uninfected    infected                                     uninfected       infected
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Real-Time PCR with SYBR Green 
          A recent study indicates that real-time RT-PCR approach is well suited for 
validation of differential expression since it is quantitative and rapid and requires 1000-
fold less RNA than conventional assays (Rajeevan et al., 2001).  Hence, to confirm the 
results obtained by semi-quantitative analysis and to more precisely quantify the fold 
induction of these differentially expressed genes, the SYBRGreen Signal Detection 
System 5700 (Applied Biosystems) was used.  For normalization of the data, ribosomal 
protein L35a was used.  This analysis (see Table 2, middle column) shows that h-IAP1 is 
over expressed 8.1 fold in HUVEC cells after 48 hours of exposure to dengue virus (D2V 
NGC).  This value is in close agreement with the 7.79 fold up-regulation identified by 
semi-quantitative RT-PCR. 
           Table 3.  Comparison of fold induction of genes obtained from SYBR Green   
                          Real Time PCR and RT-PCR  
 
                          Fold Induction                    Genes 
         SYBR Green              RT-PCR 
                   h-IAP1                    8.1                  7.79 
                  2’-5’ OAS                   72.85                > 2.65 
                2’-5’ OAS-like                   >100                > 3.55 
                    RGS2                    2.8                  3.9 
                    Gal-9                   4.59                  4.7 
                    Mx1                     N.D                >2.9 
                    MxA                  >100                 >11 
                    ESDN                    N.D                  0.45 
 44
                    TNF α                   3.76                 3.82 
                     IL1-β                 40.77               10.23 
                                                      
Northern Blot Analysis to Confirm Up-Regulation of h-IAP1  
          To further confirm the up-regulation of h-IAP1 expression during D2V infection 
Northern Blot analysis was performed on ECV 304 RNA.  10 µg of total cellular RNA 
was electrophoresed on a denaturing agarose gel and blotted overnight to a nitrocellulose 
membrane.  This membrane was probed with α-[32P] dATP-labeled oligonucleotide 
specific for h-IAP1 (Fig 16).  Ethidium bromide staining (lower panel) was used to 
confirm equal loading of mRNA samples in each lane.  A band was observed only in the 
D2V infected ECV 304 lane (right side) and was completely absent in the uninfected and 
C6/36 infected lane.  This result confirmed our previous conclusion that h-IAP1 is up- 
regulated in HUVEC cells during D2V infection. 
                                                                              
 
 
 
 
 
 
 
FIGURE 16.    Northern blot analysis was used to confirm the expression of h-IAP1 in D2V,NGC infected 
HUVEC. 10 µg of total RNA was probed with α-[32P] dCTP labeled h-IAP1fragment as described in 
Materials and Methods section. Ethidium bromide staining was used as control to confirm equal loading of 
RNA in each lane. The position of 28S ribosomal RNA (5200 bp) was used to determine the approximate 
length of the h-IAP1 transcript (5256 bp). 
28S Ribosomal RNA
h-IAP1 
 
ECV         C6/36         D2V
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Time-Course Study of the Expression of h-IAP1 and 2-5 OAS   
 
          To study in more detail the level of expression of h-IAP1 and 2’-5’ OAS genes in 
D2V infected HUVEC cells, a time-course RT-PCR study was performed over an 
interval of 15, 30 and 50 hours of D2V infection.  In both the experiments, the expression 
pattern of IL-8 gene (previously shown to be up-regulated in D2V infection) (Bosch et 
al., 2002) was used as positive control for D2V infection of HUVEC, while L35A was 
used as a housekeeper gene.  The data from the h-IAP1 experiment (Fig 17, Left panel) 
indicated that its expression was up-regulated by 15 hours of infection, and that the 
expression of the gene increased with increasing time of D2V infection.  Un-detectable 
levels of h-IAP1 were found in control samples.  The expression of 2’-5’ OAS was also 
increased with increasing time of D2V infection in HUVEC cells (Fig 18).  As early as 
15 hours post-infection, an increase in the expression of 2’-5’ OAS gene was observed.  
In two independent experiments the results were almost identical. 
 
 
Control           15 hrs          30 hrs          50 hrs  Control         15 hrs          30 hrs         50 hrs
IL-8
L35a
                         h-IAP1
100 bp
marker
FIGURE 17.    Time course RT-PCR study for expression of h-IAP1 in HUVEC. D2V,NGC infected and control cells
were incubated with D2V,NGC for 15, 30 and 50 hours and total RNA was isolated. IL-8 was used as a  positive marker
for infection, and the ribosomal RNA, L35a as a housekeeper gene. A,B represents two independent experiments.
  A         B           A          B         A          B          A          B                                                                A          B        A         B         A         B         A          B
h-IAP1
100 bp
marker
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Control               15 hrs             30 hrs        50 hrs
100 bp
marker
L35a
2’-5’ OAS
2-5 Oligoadenylate Synthetase
FIGURE 18.    Semi-quantitative analysis to study expression of 2-5
OAS at different time points of D2V,NGC infection. HUVEC cells
were infected with D2V,NGC for 15, 30 or 50 hours. RT-PCR was
performed on total RNA extracted from infected and uninfected cells.
The constitutively expressed ribosomal gene L35a was used as control.
Two independent experiments were done (A,B)
A            B           A            B             A          B            A
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TNF-α Expression in HUVEC Cells and Monocytes 
           In previous experiments (Ballard et al, 1997) where HUVEC cells were stimulated 
with TNF α, an up-regulation in the expression of h-IAP1 was observed.  So we were 
interested to know if the up-regulation of h-IAP1 expression in HUVEC during D2V 
infection involved higher TNF α expression.  To find out whether TNF α expression 
increased during D2V infection, a semi-quantitative RT-PCR was performed and L35A 
was used as a housekeeper gene.  The data from the experiment (Fig 19) confirmed that 
TNF α expression was increased 3.82 fold when HUVEC cells were infected with D2V 
(Left panel) and 10.94 fold when monocytes were infected with D2V (Right panel). 
           It has also been shown previously that stimulation with IL1-β also increased the 
expression of h-IAP1 gene (Bannerman et al., 2002) (Wang et al., 1996) (Wrighton et al., 
1996).  Hence, we performed a semi-quantitative RT-PCR using different quantities of 
uninfected and D2V infected HUVEC cDNAs (0.5, 1 and 2 µl) in the PCR step to 
compare expression of IL1-β.  The data from the experiment (Fig 20) showed a 10.23 
fold induction in the expression of IL1-β (lower band in the Fig 20) in D2V infected 
HUVEC samples.  
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Uninfected                       Infected                      Uninfected                    Infected100 bp
marker                                                1             2             4            1             2           4                1            2            4              1            2            4
HUVEC                                              Monocytes
L35a
TNF-α
FIGURE 19.    D2V,NGC infection(48 hours) induces TNF α expression in HUVEC and monocytes. The different
amounts of cDNA 1 ,2 and 4 µl were used in each group. TNF α over-expression in lane 4 was 3.82 fold in HUVEC
and 10.94 fold for monocytes.
µl
Uninfected                            Infected100 bp
marker     1             2               4               1             2               4
L35a
IL-1β
FIGURE 20.     Quantification of IL-1β up-regulation in  D2V,NGC
infected HUVEC cells (48 hours). The RT-PCR product was subjected
to agarose gel electrophoresis. L35a was used as loading control. 1 ,2
and 4 µl of cDNA were used in the PCR reaction.
µl
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TLR (1-5) Expression 
          We found in the present work that D2V infection of HUVEC cells increases the 
expression of 2-5 OAS which is one of the three pathways through which dsRNA 
recognition leads to IFN-α/β signaling pathway activation, the other two pathways being 
Protein kinase-R (PKR) and Mx.  Toll-like receptor 3 (TLR 3) has been shown to 
recognize dsRNA and activate NF-κB.  Hence we wanted to find out if TLR 3 (or any 
other TLR from 1-5) was regulated during D2V infection in HUVEC and Monocytes.  A 
multiplex RT-PCR reaction was performed (Fig 21) to find out which of the TLR from 1-
5 were involved in D2V infection.  We found that only TLR3 expression was up-
regulated 4.07 times during D2V infection in HUVEC but not in monocytes (data not 
shown) while in monocytes only the expression of TLR2 was increased 1.85 times (data 
not shown) and this was not seen in HUVEC cells (Fig. 21).  Hence in HUVEC cells 
dsRNA recognition by TLR 3 that activates NF-κB via a Myd88 dependent pathway 
might lead to production of pro-inflammatory cytokines during D2V infection. 
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FIGURE 21.    Multiplex PCR for expression of Toll-like
receptors (TLR)1-5 in uninfected and D2V infected
HUVEC and Monocytes. cDNA template was obtained
from a RT step  performed on total RNA isolated from
control and D2V,NGC infected cells 48 hours post
infection. GAPDH is given as a control for equal loading.
In the PCR step two different quantities of cDNA were
used (3, 6 µl). The solid arrows indicate the TLR genes
that were up-regulated during D2V,NGC infection in
HUVEC and monocytes. The dotted arrow indicates
constitutive expression of GAPDH.
Uninfected                Infected
3                6                  3                 6
100 bp
marker
GAPDH
TLR3
HUVEC
µl
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                                           DISCUSSION 
 
 
          A Differential Display (DD) technique was used for gene profiling in a ECV 304 
and in HUVEC.  Gene expression was compared between un-infected, samples to which 
dengue 2 viral RNA was added during cDNA synthesis (viral RNA spiked) and dengue 2 
virus infected ECV 304 cells.  We have incorporated the novel approach of spiking the 
uninfected RNA samples to avoid false postitive results.  h-IAP1 sequence identity was 
confirmed by BLAST searches on the combined Genbank/EMBL nonredundant (nr) and 
expressed sequence tag libraries (dbEST), accessed through the National Center for 
Biotechnology Information homepage (http://www.ncbi.nlm.nih.gov/BLAST).  In the 
initial experiments, the majority of differentially displayed bands turned out to be 
amplified pieces of genomic DNA.  This problem was solved once we started treating the 
extracted RNA samples with DNaseI (Martin and Pardee, 1999).  This indicates that it 
might be essential to avoid minor amounts of genomic DNA.  After using 41 different 
arbitrary primers in ECV 304 cells human inhibitor of apoptosis-1 (h-IAP1) was the only 
gene found to be differentially expressed during D2V infection.  For HUVEC cells in 
contrast, with 16 different arbitrary primers we found 7 genes to be differentially 
expressed during D2V infection.  In terms of levels of infection, we detected 10% 
infection with D2V NGC for HUVEC (Fig 12), and similarly 8% infection for ECV 304 
cells. HUVEC cells were a better model system than ECV 304 to study gene profiling 
during D2V infection.  Also, we had decreased background and less non-specific 
amplification when Titanium Taq DNA polymerase was used instead of Taq DNA 
polymerase (Bosch et al., 2000).  Hence, we suggest the use of Titanium Taq DNA 
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polymerase for future experiments while studying gene profiling in endothelial cells.  The 
list of the differentially expressed genes that found identifications when queried by 
BLAST search were h-IAP1, 2’-5’ OAS, 2-5 OAS-like, ESDN, RGS2, Mx1, MxA and 
Gal-9. 
          In a previous study  differential display technique was performed to identify 
mRNAs with enhanced expression levels in cytomegalovirus-infected cells as compared 
to mock-infected cells. The found that cytomegalovirus inducted expression of 
interferon-responsive mRNAs (Zhu et al., 1997).    
           h-IAP1/ cIAP2 belongs to the family of human inhibitors of apoptosis (IAP).  The 
family of human IAP genes (six genes including xIAP, h-IAP1, h-IAP2/ cIAP1, survivin 
and nIAP) was first described in baculovirus, and they share the baculovirus IAP repeat 
(BIR) which seems to be essential and sufficient to cause the anti-apoptotic effect 
(Deveraux and Reed, 1999; Vucic et al., 1998).  IL1-β, TNF α and lipopolysaccharide 
stimuli, which activate NF-κB, have been shown to up-regulate the expression of h-IAP1 
in HUVEC (Stehlik et al., 1998).  Hence, h-IAP1 might not only have an anti-apoptotic 
but also a pro-inflammatory effect.  It has been demonstrated that flaviviruses, including 
dengue, elicit a response in which NF-κB dependent expression of cytokines occurs, and 
that NF-κB regulates the expression of anti-apoptotic genes  (including h-IAP1) through 
the TNF α pathway to protect the cells from apoptosis (Hong et al., 2000).  It is also 
known that h-IAP1 modulates the TNF α induced NK-κB activity to inhibit apoptosis 
(Bosch et al., 2002; Chu et al., 1997; Stehlik et al., 1998).  Hence, there is a positive 
feedback mechanism operating between NF-κB and h-IAP1 that contributes to cell 
survival following TNF stimulus, initially in which NF-κB activates the expression of h-
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IAP1, and in turn h-IAP1 interacts with IκBα (a cytoplasmic inhibitor of NF-κB) and 
stimulates its proteolytic breakdown to release free NF-κB.  This free NF-κB is 
subsequently translocated to the nucleus and further activates h-IAP1 expression (Chu et 
al., 1997).  h-IAP1 has also been shown to interact with TNF-receptor associating factor 
2 (TRAF2) and increase its expression in the absence of TNF α stimulation (Chu et al., 
1997; Rothe et al., 1995; Uren et al., 1996).  Overall, in the TNF signaling pathway, h-
IAP1 seems to potentiate its own expression, by interacting with TRAF2, a cytoplasmic 
protein and, by phosphorylation of Iκß using the c-terminal domain of h-IAP1, which in 
turns leads to the activation and translocation of NF-κß.  Once expressed h-IAP1 exerts 
its anti-apoptotic effect downstream in the TNF α signaling pathway by stimulating 
proteolytic cleavage of terminal caspase-3, -7 and cytochrome-c induced caspase–9 
thereby inhibiting protein degradation and caspase-mediated apoptosis (Deveraux et al., 
1998; Lee and Collins, 2001; Roy et al., 1997).  We found the h-IAP1 gene to be up- 
regulated 8.1 fold in HUVEC during dengue 2 virus infection.  h-IAP1 along with the 
other members of the IAP family of proteins has been shown to suppress the cell death 
response to viral infection. Inhibition of apoptosis involving h-IAP1 may be a possible 
mechanism by which apoptosis is controlled in HUVEC cells during infection, and 
consequently 
viral persistence and inflammation prevail.  Hence from the DD results obtained we can 
conclude that D2V over expresses h-IAP1 in endothelial cells, which may help to 
overrule the apoptotic signals and increase cell survival. 
          It is known that NF-κB up-regulates the expression of h-IAP1 by TNF α 
stimulation.  IL1- ß has also been shown to up-regulate expression of h-IAP1 in HUVEC 
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cells (Wang et al., 1996; Wrighton et al., 1996).  This up-regulation is very likely to be 
NF-κB dependent because IL1- ß activates NF-κB through the kinase cascade.  Since h-
IAP1 was up regulated during D2V infection we investigated whether D2V infection 
leads to higher levels of TNF α and IL1-β mRNA.  There was an increase in the 
expression of TNF α in HUVEC as well as in primary human monocytes and of IL1-ß in 
HUVEC after D2V infection.  Previous studies have shown that dengue infection elicits a 
response, which leads to NF-κB dependent over expression of cytokines (Gagnon et al., 
1999).  Both IL-1ß and TNF α are up regulated during D2V infection, which would in 
theory indicate that the expression of hIAP-1 could be caused by the upstream effect of 
IL-1-ß and TNF α.  We found that TNF α and IL1-β expression increased 3.8 fold and 
10-40 fold respectively.  TNF α and IL1-β, pro-inflammatory cytokines could contribute 
to vascular leakage at the site of inflammation in dengue infection and regulate the 
expression of proteins that modulate inflammatory response (Reynolds et al., 2002).  
Hence, the up-regulation of TNF α and IL1-β may be partly responsible for the plasma 
leakage during D2V infection. 
 
Antiviral Response            
 
          The expression levels of 2'-5' OAS, Mx1 and MxA were elevated during D2V 
infection in HUVEC.  All 3 of theses genes are involved in recognition of dsRNA and 
belong to the IFN-induced antiviral pathway that provides an early line of defense against 
viral infections.  Mx1 and MxA proteins, which belong to the Mx pathway, and the 2’-5’ 
OAS gene, which belongs to the 2’-5’ OAS pathway, are induced preferentially by the 
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IFN-type1 pathway (IFN α/β).  In the presence of dsRNA 2’-5’ OAS binds to inactive 2’-
5’ OAS dependent RNase (RNase L) and coverts it to activated RNase L, which is a 
reversible process.  RNase L leads to extensive degradation of viral RNA and selectively 
blocks viral replication (Hovanessian, 1991).  Mx proteins (MxA, Mx1), which belong to 
the family of GTPases, have been shown to impair viral growth at the transcriptional 
level and might also block the intracellular trafficking of nucleocapsids (Hefti et al., 
1999; Horisberger, 1992; Horisberger, 1995; Landis et al., 1998; Muller et al., 1992).  
Our findings indicate that 2’-5’ OAS, Mx1, and MxA are up-regulated 72.85, more than 
2.9 and more than 100 fold respectively.   
          The finding that 2’-5’ OAS system is activated during D2V infection is of 
particular importance because genetically deficient PKR-RNase L mouse cells retained 
sensitivity to inhibition of IFN suggesting that IFN response during dengue virus 
infection is 2’-5’ OAS and PKR independent (Diamond and Harris, 2001).  NS5A from 
hepatitis C virus (HCV) (Flavivirus) has been shown to inhibit IFN-induced PKR to 
maintain global mRNA translation rate during early infection (He et al., 2001).  This 
indicates that instead of a PKR independent IFN response, NS5 protein from dengue 
virus might be blocking IFN-induced PKR to favor higher levels of viral replication.    
          The up-regulation of genes involved in the type-1 IFN pathway is important 
because the IFN system (innate primary response) plays a role in limiting viral spread 
before the activation of the immune system involving T-cell and B-cell response in 
dengue virus infection. 
          2’-5’ Oliogoadenylate synthetase-like gene (OASL) is highly homologous to 2’-5’ 
OAS (OAS).  It is a 56-kDa protein, which shares the functional domain with the OAS 
 56
proteins, binds DNA and dsRNA but it cannot activate RNase L to cause viral RNA 
degradation like the 2’-5’ OAS genes (Hartmann et al., 1998; Hovnanian et al., 1999; 
Rebouillat et al., 1998).  The catalytic activity OASL is still not known.  We found 2’-5’ 
OAS to be up-regulated more than 100 fold in HUVEC cells during D2V infection.                 
 
          TLR3 has been shown to recognize dsRNA, activate NF-κB and induce cytokine 
production through the MyD88 dependent pathway (Alexopoulou et al., 2001).  It is also 
known that NF-κB regulates the expression of h-IAP1, hence TLR3 could also be 
involved in the increased expression of h-IAP1 found here.  dsRNA recognition by TLR3 
also stimulates IFN type1 pathway in endothelial cells (Miettinen et al., 2001).  Hence, 
TLR3 might be involved in induction of cytokines and the anti-viral pathway in 
endothelial cells.  In our experiments, TLR3 was up regulated approximately 4 fold in 
HUVEC cells during D2V infection.  
 
          MxA, Mx1, 2’-5’ OAS and TLR3 recognize dsRNA and induce IFN type1 
pathway.  So theoretically TLR3, 2-5 OAS, MX1 and MXA could block the translation 
of D2V viral genes.  
 
          The Regulator of G-protein signaling- 2 (RGS2) is a member of the Regulators of 
G-protein signaling proteins that regulate G-protein linked signaling pathways by 
enhancing the hydrolyses of GTP to GDP thus limiting the time of activation.  RGS2 also 
induces T-cell proliferation. Cell stress has been shown to induce higher RGS2 mRNA 
levels (Kehrl and Sinnarajah, 2002; Song et al., 2001).  It was found to be up regulated 
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3.9 fold in infected HUVEC cells.  The Mx genes, which belong to the type-1 IFN 
pathway, have GTPase activity (GTP → GDP) and protein-protein interaction 
interactions, which indicates their importance in regulating signaling through the G 
protein-coupled receptor (GPCR) and protein trafficking (Horisberger, 1992). It has been 
demonstrated that Kaposi’s sarcoma herpervirus (KSHV) encodes a G protein-coupled 
receptor (GPCR) that induces endothelial cells to constitutively express NF-κB and 
increased secretion of the chemokine IL-8 (Shepard et al., 2001).  It is important to note 
that all chemokines like IL-8 act via seven-transmembrane domain receptors that are 
coupled to heterotrimeric GTP-binding proteins (GPCR) (Loetscher and Clark-Lewis, 
2001).  Regulators of G-protein signaling (RGS) negatively regulate signaling through G-
protein coupled receptors. We found that RGS2 expression was up-regulated 3.9 fold 
during D2V infection in endothelial cells.  Classical symptoms of dengue virus infection 
are inflammation and plasma leakage.  Hence, we postulate that RGS2 expression might 
be up-regulated in HUVECs in response to dengue virus infection to regulate chemokine 
secretion which are mediators of inflammation and also to potentiate signaling through 
Mx pathway similar to T-cells. 
          Among other genes that were differentially expressed during HUVEC D2V NGC 
infection was ESDN.  ESDN, which was recently discovered, is a novel neuropilin-like 
type-1 transmembrane protein that is considered to regulate vascular cell growth.  
Neuropilins mediate chemorepulsive as well as chemoattractive signals.  In endothelial 
cells neuropilin-1 acts as a co-receptor for VEGF, enhancing VEGF’s biological function.  
Also, ESDN expression is up-regulated in injured arteries and its up-regulation causes 
decreased cell growth (Kobuke et al., 2001).  ESDN expression was found to be down 
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regulated 2.2 fold in infected HUVEC cells.  The function of ESDN is not clearly known. 
It might involve chemoattractive or chemorepulsive responses during D2V infection of 
HUVEC cells.  But, the significance of its down-regulation is not quite clear.  This 
fluctuation in expression deserves further study. 
 
          Lastly, Gal-9 belongs to the family of Ca2+ dependent galactoside-binding lectins 
that modulate a variety of cellular activities such as cell proliferation/cell death, cell 
adhesion and chemoattraction (Barondes et al., 1994; Lahm et al., 2000; Matsumoto et 
al., 1998; Oda et al., 1991; Paroutaud et al., 1987; Tureci et al., 1997; Wada and Kanwar, 
1997; Wada et al., 1997).  Gal-9 is an eosinophil chemoattractant expressed in HUVEC 
cells and in immune cells like macrophages, B and T-cells and mast cells (Chabot et al., 
2002).  Hence, Gal-9 is one of the chemoattractments that accumulates eosinophils to the 
site of inflammation.  The pro-inflammatory cytokine IL1-β (itself up-regulated during 
dengue virus infection) has been shown to enhance the expression of Gal-9 (Yoshida et 
al., 2001).  Dengue virus infection leads to inflammation and plasma leakage in vascular 
endothelia.  This might be a result of action of cytokines and cationic chemokines that act 
on the vascular endothelium and cause transient leakage.  Gal-9 was found to be up 
regulated 4.7 fold in D2V infected HUVEC cells.  Hence, there is a possibility that Gal-9 
is responsible for the accumulation of eosinophils at the surface of vascular endothelium 
leading to inflammation and plasma leakage during dengue virus infection.  In fact, it is 
possible that IL1-β leads to over expression of Gal-9 in HUVEC cells during D2V 
infection.  Gal-9 has also been described as a urate transporter / channel (Spitzenberger et 
al., 2001).    
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           Most of the genes found by DD to be regulated at the level of mRNA can 
potentially explain in part the pathogenesis of dengue virus infection in HUVEC cells. 
The three main pathways found to be activated during D2V infection in this thesis are, 
first the TNF α signaling pathway, second one, the IL1-β signaling pathway, and third, 
the type-1 IFN pathway (IFN-α and IFN-β).  The genes involved in the TNF α signaling 
pathway that we found to be up-regulated are TNF α itself and h-IAP1.  h-IAP1 
expression is transcriptionally controlled by NF-κB, which regulates expression of pro-
inflammatory cytokines like TNF α and IL1-β (Bannerman et al., 2002; Chu et al., 1997; 
Hong et al., 2000; Stehlik et al., 1998).  Hence, dengue virus might be activating these 
two genes to induce a pro-inflammatory and an anti-apoptotic response.  IL1-β can also 
activate h-IAP1 expression (Wrighton et al., 1996).  IL1-β expression leads to activation 
of NF-κB and hence could potentially regulate h-IAP1 expression.  Hence, to identify the 
function of h-IAP1 expression during D2V infection further study is required.  IL1-β also 
has been shown to enhance expression of Gal-9, which is an eosinophil chemoattracttant 
(Yoshida et al., 2001).  Hence, the possibility that IL1-β, a pro-inflammatory cytokine, 
might up-regulate expression of Gal-9 and h-IAP1 makes its regulation during dengue 
virus infection very important.  Moreover, TNF α and IL1-β has been shown to induce 
significant microvascular leakage in a recent study (Reynolds et al., 2002).  Plasma 
leakage is clearly involved during dengue virus infection.  Overall from previous data 
about the TNF α and IL1-β pathway, and the findings in our experiments, indicate that 
these two pro-inflammatory cytokines might play a very important role during dengue 
virus infection.  The type-1 IFN pathway might be activated as an anti-viral mechanism 
to fight against D2V infection before the immune response involving T-cell and B-cell 
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activation occurs which will help to control the spread of viral infection.  Contrary to 
earlier findings, we found the 2’-5’ OAS pathway gene to be up-regulated during D2V 
infection along with Mx pathways genes, but we still do not know whether PKR, the 3rd 
pathway that belongs to the type-1 IFN pathway is activated due to D2V infection in 
HUVEC cells.  The study identifies three pathways activated in HUVEC during D2V 
infection not known previously (Fig. 22).  
           The rationale for the activation of antiapoptotic pathway during the viral infection 
is to allow for the virus to replicate before pathogenic responses destroy the host cell.  
The time in which apoptosis is inhibited would serve the virus to complete its cycle of 
infection and form viable particles that are passed to neighboring cells. 
          On the other hand, if there is a limit to the infectivity of the virus, eventually, the 
viral load would be high enough to cause cellular death.  Therefore, there are antiviral 
mechanisms in place, like the type-I IFN response, the 2’-5’OAS the Mx (MxA and Mx1) 
genes whose expression can target viral destruction by uncapping the viral RNA and 
interfere with translation.  There must by a fine tuning of those mechanisms that the virus 
has evolved to allow its own replication as well as those mechanisms that are evolved to 
control the progression of the infection.  As a product of the first type of viral interaction, 
inflammation occurs, which in turn activates the antiviral response through IFN α/β.  The 
second type of response, the one directed toward downplaying the cellular response, 
would be signaling through G protein coupled receptors.  G protein coupled receptors, 
necessary for chemokine secretion are regulated by RGS family of proteins.  RGS2, a 
member of the RGS family of proteins was found to be upregulated by dengue virus 
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NGC infection.  This may be a way in which the cell down regulates the inflammatory 
response once it has activated during dengue virus NGC infection. 
           
The infected host has two roles: 
To activate the innate response, by increasing the IFN  Type-1 IFN (α/β) response, 2’-5’ 
OAS, MxA and Mx1 expression to generate antiviral response to block infection.  Also, 
to stimulate the immune system to generate an immune response and to cause 
inflammation and stimulation of the immunological effectors cells.  Therefore, the 
infected cell is responsible of controlling the infection, directly and indirectly through 
antibody and cell mediated response. 
          Hence, for future experiments it is important to study the activation of PKR 
pathway and its phosphorylation to study if PKR is involved during dengue virus 
infection.  Also, perform co-immunoprecipitation studies for NS1 and NS5 proteins from 
D2V NGC to see if it regulates Type-I IFN pathway by interacting and blocking PKR 
pathway.  It is interesting to study if the genes that were differentially expressed in 
HUVECs during D2V infection are also differentially expressed in other Flavivirus 
infection (e.g. West Nile, Yellow Fever).      
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